Case Studies

Strategically Creative Branding – Building a Cohesive Corporate Brand Identity for Pharvaris

By

Client: Pharvaris Challenge Pharvaris, a pharmaceutical company developing innovative oral bradykinin B2 receptor antagonist therapies for bradykinin-mediated diseases like hereditary angioedema (HAE), needed to establish a consistent and compelling corporate brand identity. They required a comprehensive Corporate Brand Communications Guide to ensure a unified look and feel across all online and offline communications, reflecting their […]

Strategically Creative Branding – Building a Cohesive Corporate Brand Identity for Pharvaris Read More »

Enhancing a Company’s Scientific Presence at Key Hematology & Oncology Congresses Through Exhibition Panel Scientific Content Development, Infographics & Creative Design

By

Client: Curis Pharma   Challenge: Curis Pharma, a biopharmaceutical company focused on developing innovative therapeutics for cancer treatment, sought to effectively communicate the science behind their IRAK4/FLT3 inhibitor therapy in development for lymphoma and leukemia indications. Curis needed visually engaging and scientifically accurate exhibition booth panels for major international congresses, including the European Hematology Association

Enhancing a Company’s Scientific Presence at Key Hematology & Oncology Congresses Through Exhibition Panel Scientific Content Development, Infographics & Creative Design Read More »

Market Intelligence

By

PHASE II Market Intelligence recently mapped and profiled 21 European CLL Centers of Excellence on behalf of a life sciences client.. The goal was to identify the top 20 European trial centers of excellence across European countries. Key criteria used to profile the centers included: Hospital Type e.g. International, National or Regional?; Hematology Specialty? Principle

Market Intelligence Read More »

Early Strategic Advisory Boards

By

PHASE II moderated Expert Advisory Boards helped determine an optimized product TPP, TCP and clinical trial strategy. ​ PHASE II has recently managed a series of Strategy Development Advisory boards in the US, Europe and the Asia Pacific Regions– for a small biopharmaceutical company with products in phase 2 to support planning for phase 3

Early Strategic Advisory Boards Read More »

Using AI for market intelligence insights

By

Applying AI for earlier diagnosis and ‘enriched populations’​ PHASE II | AI, is collaborating with multi-stakeholder consortiums encompassing life science companies, healthcare authorities, healthcare professionals and tech providers to deploy AI-powered predictive analytics & machine learning solutions that can detect disease early – up to five years before it develops. ​ ​ Identification of sub-clinical

Using AI for market intelligence insights Read More »

Market Access Strategy

By

Market access strategies, optimized health economics outcomes research programs, and value demonstration communications. As EU healthcare system payers and providers continue to strive for value from life science industry therapies and technologies, our Market Access & HEOR network of experts has been supporting clients in the following areas: Market Access, Value Demonstration, HEOR Strategy Development

Market Access Strategy Read More »

Strategy Planning

By

Utilizing AI solutions to transform our capabilities​. ​Over the past past 18 months PHASE II | AI has been utilizing AI tools as standalone applications or with custom infrastructure, ​ to transform our work. Examples have included: ​ Natural Language Processing (NLP) AI: used in market research and analysis assignments for clients which involve transcription,

Strategy Planning Read More »